Engineered Antibodies Show Promise Against EBV Microplastics Found in Prostate Tissue
Researchers have reported encouraging progress toward a preventive strategy against the Epstein-Barr virus infection (EBV), a widespread pathogen associated with infectious mononucleosis, multiple sclerosis and certain lymphomas. The findings, published in Cell Reports Medicine, demonstrate successful laboratory testing of engineered monoclonal antibodies in mouse models.
Month: Current Affairs - March 01, 2026
Category: Health | Biotechnology